BMS-986016 drug page Clinical trials

Trials with BMS-986016

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
1Recruiting
9Countries
738Planned patients

Showing 1–2 of 2

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Recruiting Phase 2 353 patients NCT03026140

In this exploratory study, patients with stage 1-3 adenocarcinoma of the colon with no signs of distant metastases will be treated with short-term immunotherapy + novel IO combinations (i.e. anti-IL 8, COX2-inhibitors, anti-LAG3). This tre…

Netherlands Mar 2017 – Mar 2032 Interventional
A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
Finished Phase 2 385 patients NCT02060188

The purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in meaningful tumor size reduction, in participants with colon cancer that has come back or has spread, a…

United States, Australia, Belgium, Canada and 4 more Mar 2014 – Oct 2024 Interventional

Where the recruiting trials are